Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice

S Collins1, K W Daniel, A E Petro

  • 1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27710, USA.

Endocrinology
|January 1, 1997
PubMed

Insights

High-fat diets can cause obesity by affecting adipocyte adrenergic receptors. A beta 3AR agonist prevented diet-induced obesity in A/J mice by maintaining receptor function and promoting brown fat activity.

Area of Science:

  • Metabolic research
  • Obesity research
  • Pharmacology

Background:

  • High-fat diets are linked to obesity development.
  • Adipocyte adrenergic receptor (AR) expression and function are adversely affected by fat intake.
  • Beta 3AR agonists can reduce adipose tissue and improve thermogenesis.

Purpose of the Study:

  • To investigate if chronic high-fat diet supplementation with a beta 3AR agonist (CL316,243) prevents diet-induced obesity.
  • To determine if the obesity-preventing effects are sustained with prolonged treatment.
  • To explore the impact on adipocyte adrenergic receptor expression and function.

Main Methods:

  • C57BL/6J and A/J mice were fed low-fat, high-fat, or high-fat diets with CL316,243.
  • Body weight, food intake, and beta-adrenergic stimulation of adenylyl cyclase were measured.
  • Expression of beta 3AR, beta 1AR, and uncoupling protein was analyzed in adipose tissues.

Main Results:

  • High-fat diet increased weight gain in both mouse strains, with B/6J gaining more than A/J.
  • CL316,243 prevented diet-induced obesity in A/J mice but not B/6J mice.
  • CL316,243 maintained beta 3AR and beta 1AR expression and stimulated adenylyl cyclase activity in A/J mice, promoting functional brown adipose tissue (BAT).

Conclusions:

  • The prevention of diet-induced obesity by chronic CL316,243 treatment depends on the development of functional brown adipose tissue.
  • Mouse strain differences in adrenergic receptor regulation influence susceptibility to diet-induced obesity and response to beta 3AR agonists.
  • Targeting beta 3AR may be a viable strategy for obesity prevention, contingent on individual metabolic profiles and BAT elaboration.

Related Concept Videos